Lupa

Search the repository Help

A- | A+ | Print
Query: search in
search in
search in
search in
* old and bologna study programme

Options:
  Reset


171 - 180 / 220
First pagePrevious page13141516171819202122Next pageLast page
171.
172.
173.
174.
175.
Poročilo raziskave med tekači in tekačicami
Eva Podovšovnik, Miha Lesjak, 2015, published professional conference contribution (invited lecture)

Keywords: maraton, Istra, športne prireditve
Published in RUP: 15.10.2015; Views: 3504; Downloads: 63
URL Link to full text

176.
Športni turizem in vplivi velikih športnih prireditev na lokalno skupnost
Miha Lesjak, 2014, independent scientific component part or a chapter in a monograph

Keywords: turizem, športni turizem, lokalno prebivalstvo
Published in RUP: 15.10.2015; Views: 4788; Downloads: 354
URL Link to full text

177.
178.
Ergo-Cell : a multi-sensor system offering new opportunities for research in elderly
Nejc Šarabon, Miha Peroša, Jure Pražnikar, Helmut Kern, 2015, published scientific conference contribution abstract

Keywords: measurements, mobile technology, physiology, ergonomics
Published in RUP: 15.10.2015; Views: 3132; Downloads: 38
URL Link to full text

179.
Endoglin (CD105) silencing mediated by shRNA under the control of Endothelin-1 promoter for targeted gene therapy of Melanoma
Nataša Tešić, Urška Kamenšek, Gregor Serša, Simona Kranjc Brezar, Monika Savarin, Urša Lampreht Tratar, Véronique Préat, Gaëlle Vandermeulen, Miha Butinar, Boris Turk, Maja Čemažar, 2015, original scientific article

Abstract: Endoglin (CD105), a transforming growth factor (TGF)-% coreceptor, and endothelin-1, a vasoconstrictor peptide, are both overexpressed in tumor endothelial and melanoma cells. Their targeting is therefore a promising therapeutic approach for melanoma tumors. The aim of our study was to construct a eukaryotic expression plasmid encoding the shRNA molecules against CD105 under the control of endothelin-1 promoter and to evaluate its therapeutic potential both in vitro in murine B16F10-luc melanoma and SVEC4-10 endothelial cells and in vivo in mice bearing highly metastatic B16F10-luc tumors. Plasmid encoding shRNA against CD105 under the control of the constitutive U6 promoter was used as a control. We demonstrated the antiproliferative and antiangiogenic effects of both plasmids in SVEC4-10 cells, as well as a moderate antitumor and pronounced antimetastatic effect in B16F10-luc tumors in vivo. Our results provide evidence that targeting melanoma with shRNA molecules against CD105 under the control of endothelin-1 promoter is a feasible and effective treatment, especially for the reduction of metastatic spread.
Keywords: melanoma, electroporation, endoglin (CD105), endothelin-1, gene therapy
Published in RUP: 14.10.2015; Views: 3833; Downloads: 131
URL Link to full text

180.
Search done in 0 sec.
Back to top
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica